Therapy options in pulmonary alveolar proteinosis

Therapeutic Advances in Respiratory Disease

Volumn 4, Issue 4, 2010, Pages 239-248

  Luisetti, Maurizio ^a   Kadija, Zamir ^b   Mariani, Francesca ^b   Rodi, Giuseppe ^b   Campo, Ilaria ^b   Trapnell, Bruce C ^c  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

anti GM CSF; autoantibodies; granulocyte macrophage colony stimulating factor; plasmapheresis; pulmonary surfactant; whole lung lavage

Indexed keywords

AMBROXOL; ANTIBIOTIC AGENT; AUTOANTIBODY; CHYMOTRYPSIN; CORTICOSTEROID; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR ANTIBODY; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR RECEPTOR; HEPARIN; POTASSIUM IODIDE; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; RITUXIMAB; TRYPSIN;

ADULT RESPIRATORY DISTRESS SYNDROME; ANTIBODY BLOOD LEVEL; B LYMPHOCYTE; BONE MARROW TRANSPLANTATION; CLINICAL TRIAL; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE COURSE; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DRUG EFFECT; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG MEGADOSE; DRUG TOLERABILITY; EXERCISE TOLERANCE; EXTRACORPOREAL OXYGENATION; FIBEROPTIC BRONCHOSCOPY; GENE MUTATION; HUMAN; HYDROTHORAX; HYPOXEMIA; LONG TERM CARE; LUNG ALVEOLUS PROTEINOSIS; LUNG LAVAGE; LUNG TRANSPLANTATION; LYMPHOCYTE DEPLETION; LYSINURIC PROTEIN INTOLERANCE; MULTIPLE CYCLE TREATMENT; NONHUMAN; PLASMAPHERESIS; PNEUMONIA; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; SEPSIS; SIGNAL TRANSDUCTION; SURVIVAL RATE; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ANIMALS; AUTOANTIBODIES; BRONCHOALVEOLAR LAVAGE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; PULMONARY ALVEOLAR PROTEINOSIS; RESPIRATORY INSUFFICIENCY; SEVERITY OF ILLNESS INDEX;

EID: 77955567123     PISSN: 17534658     EISSN: None     Source Type: Journal    
DOI: 10.1177/1753465810378023     Document Type: Review

References (70)

1. Alberti, A., Luisetti, M., Braschi, A., Rodi, G., Iotti, G., Sella, D. et al. (1996) Bronchoalveolar lavage fluid composition in alveolar proteinosis. Early changes after therapeutic lavage. Am J Respir Crit Care Med 154: 817-820.
2. Arai, T., Hamano, E., Inoue, Y., Tazawa, R., Nukiwa, T., Sakatani, M. et al. (2004) Serum neutralizing capacity of GM-CSF reflects disease severity in a patients with pulmonary alveolar proteinosis successfully treated with inhaled GM-CSF. Respir Med 98: 1227-1230.
3. Arora, P.L. ( 1968) Alveolar proteinosis, experience with trypsin therapy. Am J Med 44: 889-899.
4. Barraclough, R.M. and Gillies, A.J. ( 2001) Pulmonary alveolar proteinosis: a complete response to GM-CSF therapy. Thorax 56: 664-665.
5. Beccaria, M., Luisetti, M., Rodi, G., Corsico, A., Zoia, M.C., Colato, S. et al. (2004) Long term durable benefit after whole lung lavage in pulmonary alveolar proteinosis. Eur Respir J 23: 526-531.
6. Ben-Abraham, R., Greenfield, A., Rozenman, J. and Ben-Dov, I.H. ( 2002) Pulmonary alveolar proteinosis: step-by-step perioperative care of whole lung lavage procedure. Heart Lung 31: 43-49.
7. Bingisser, R., Kaplan, V., Zollinger, A. and Russi, E.W. ( 1998) Whole-lung lavage in alveolar proteinosis by a modified lavage technique. Chest 113: 1718-1719.
8. Bonfield, T.L., Kavuru, M. and Thomassen, M.J. ( 2002) Anti GM-CSF titer predicts response to GM-CSF therapy in pulmonary alveolar proteinosis. Clin Immunol 105: 817-820.
9. Borie, R., Debray, M.-P., Laine, C., Aubier, M. and Crestani, B. (2009) Rituximab therapy in autoimmune pulmonary alveolar proteinosis. Eur Respir J 33: 1503-1506.
10. Brodsky, I. ( 1961) Pulmonary alveolar proteinosis, remission after therapy with trypsin and chymotrypsin. N Engl J Med 265: 935-938.
11. Ceruti, M., Rodi, G., Stella, G.M., Adami, A., Bolongaro, A., Baritussio, A. et al. (2007) Successful whole lung lavage in pulmonary alveolar proteinosis secondary to lysinuric protein intolerance: a case report. Orphanet J Rare Dis 2: 14.
12. Cheng, S.L., Chang, H.T., Lau, H.P., Lee, L.N. and Yang, P.C. ( 2002) Pulmonary alveolar proteinosis: treatment by bronchofiberscopic lobar lavage. Chest 122: 1480-1485.
13. Davidson, J.M. and Macleod, W.M. ( 1969) Pulmonary alveolar proteinosis. Br J Dis Chest 63: 13-28.
14. Dirksen, U., Hattenhorst, U., Schneider, P., Schroten, H., Göbel, U., Böcking, A. et al. (1998) Defective expression of granulocyte-macrophage colony-stimulating factor/interleukin-3/interleukin-5 receptor common beta chain in children with acute myeloid leukemia associated with respiratory failure. Blood 92: 1097-1103.
15. Dirksen, U., Nishinakamura, R., Gronek, P., Hattenhorst, U., Nogee, L., Murray, L. et al. (1997) Human pulmonary alveolar proteinosis associated with a defect in GM-CSF/IL-3/IL-5 receptor common beta chain expression. J Clin Invest 100: 2211-2217.
16. Dogru, D., Yalcin, E., Aslan, A.T., Ocal, T., Ozcelik, U., Gucer, S. et al. (2009) Successful unilateral lung lavage in a child with pulmonary alveolar proteinosis. J Clin Anesth 21: 127-130.
17. Douda, D.N., Farmakoski, N., Dell, S., Grasemann, H. and Palaniyar, N. (2009) SP-D counteracts GM-CSF-mediated increase of granuloma formation by alveolar macrophages in lysinuric protein intolerance. Orphanet J Rare Dis 4: 29.
18. Dranoff, G., Crawford, A.D., Sadelein, M., Rearn, B., Rashid, A., Bronson, R.T. et al. (1994) Involvement of granulocyte/macrophage colony-stimulating factor in pulmonary homeostasis. Science 264: 713-716.
19. Du Bois, R.M., McAllister, W.A.C. and Branthwaite, M.A. ( 1983) Alveolar proteinosis: diagnosis and treatment over a 10-year period. Thorax 38: 360-363.
20. Goldstein, L.S., Kavuru, M.S., Curtsi-McCarthy, P., Christie, H.A., Farver, C. and Stoller, J.K. ( 1998) Pulmonary alveolar proteinosis: clinical features and outcome. Chest 114: 1357-1362.
21. Hammon, W.E., McCaffree, D.R. and Cucchiara, A.J. ( 1993) A comparison of manual to mechanical chest percussion for clearance of alveolar material in patients with pulmonary alveolar proteinosis. Chest 103: 1409-1412.
22. Hashizume, T. ( 2002) Pulmonary alveolar proteinosis successfully treated with ambroxol. Intern Med 41: 1175-1178.
23. Inoue, Y., Trapnell, B.C., Tazawa, R., Arai, T., Takada, T., Hizawa, N. et al. (2008) Characteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in Japan. Am J Respir Crit Care Med 177: 752-762.
24. Jansen, H.M., Zuurmond, W.W., Roos, C.M., Schreuder, J.J. and Bakker, D.J. ( 1987) WLL under hyperbaric oxygen conditions for alveolar proteinosis with respiratory failure. Chest 91: 829-832.
25. Jay, S.J. ( 1979) Pulmonary alveolar proteinosis: successful treatment with aerosolized trypsin. Am J Med 66: 348-354.
26. Kavuru, M., Bonfield, T.L., Thomassen, M.J., Seymour, J.F. and Presneill, J.J. ( 2003) Plasmapheresis, GM-CSF, and alveolar proteinosis. Am J Respir Crit Care Med 167: 1036-1037.
27. Kavuru, M.S., Sullivan, E.J., Piccin, R., Thomassen, M.J. and Stoller, J.K. ( 2000) Exogenous granulocytemacrophage colony stimulating factor administration for pulmonary alveolar proteinosis. Am J Respir Crit Care Med 161: 1143-1148.
28. Kitamura, T., Tanaka, N., Watanabe, J., Uchida, K., Kanegasaki, S., Yamada, Y. et al. (1999) Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocytemacrophage colony-stimulating factor. J Exp Med 190: 875-880.
29. Larson, R.K. and Gordinier, R. ( 1965) Pulmonary alveolar proteinosis: report of six cases, review of the literature, and formulation of a new theory. Ann Intern Med 62: 292-312.
30. Luisetti, M., Rodi, G., Perotti, C., Campo, I., Mariani, F. and Pozzi, E. (2009) Plasmapheresis for treatment of pulmonary alveolar proteinosis. Eur Respir J 33: 1220-1222.
31. Luisetti, M. and Trapnell, B.C. ( 2010) Pulmonary alveolar proteinosis. In: Schwarz, M.I. and King, T.E. (eds). Interstitial Lung Disease, 5th edition, in press.
32. Marchiori, E., Souza, C.A., Barbassa, T.G., Escuissato, D.L., Gasparetto, E.L. and Souza Jr, A.S. ( 2007) Silicoproteinosis: high resolution CT findings in 13 patients. Am J Roentgeneol 189: 1402-1406.
33. McDowell, C., Williams, S.E. and Hinds, J.R. ( 1959) Pulmonary alveolar proteinosis; report of a case. Australians Ann Med 8: 137-142.
34. Martinez-Moczygemba, M., Doan, M.L., Elidemer, O., Fan, L.L., Cheung, S.W., Lei, J.T. et al. (2008) Pulmonary alveolar proteinosis caused by deletion of GM-CSFRα gene in the X chromosome pseudoautosomal region 1. J Exp Med 205: 2711-2716.
35. Michaud, G., Reddy, C. and Ernst, A. (2009) Whole-lung lavage for pulmonary alveolar proteinosis. Chest 136: 1678-1681.
36. Nicholas, J.J. ( 1965) Pulmonary alveolar proteinosis. A case with improvement after a short course of endobronchial instillations of heparin. Ann Intern Med 62: 358-366.
37. Nishinakamura, R., Wiler, R., Dirksen, U., Morikawa, Y., Arai, K., Miyajima, A. et al. (1996) The pulmonary alveolar proteinosis in granulocyte/macrophage colony-stimulating factor/interleukins 3/5 beta c receptor deficient mice is reversed by bone marrow transplantation. J Exp Med 183: 2657-2662.
38. Paquet, C. and Karsli, C. (2009) Technique of lung isolation for whole lung lavage in a child with pulmonary alveolar proteinosis. Anesthesiology 101: 190-192.
39. Parker, L.A. and Novotny, D.B. ( 1997) Recurrent alveolar proteinosis following double lung transplantation. Chest 111: 1457-1458.
40. Perez, A. and Rogers, R.M. ( 2004) Enhanced alveolar clearance with chest percussion therapy and positional changes during whole lung lavage for alveolar proteinosis. Chest 125: 2351-2356.
41. Prakash, U.B.S., Barham, S.S., Carpenter, H.A., Dines, D.E. and Marsh, H.M. ( 1987) Pulmonary alveolar lipoproteinosis: experience with 34 cases and a review. Mayo Clin Proc 62: 499-519.
42. Rahaman, A., Moodley, J.A. and Phillips, M.J. ( 2004) Pulmonary alveolar proteinosis associated with psoriasis and complicated by mycobacterial infection: successful treatment with granulocyte-macrophage colony stimulating factor after a partial response to whole lung lavage. Respirology 9: 419-422.
43. Ramirez, J., Kieffer Jr, R.F. and Ball Jr, W.C. ( 1965) Bronchopulmonary lavage in man. Ann Intern Med 63: 819-828.
44. Ramirez, J., Schultz, R.B. and Dutton, R.E. ( 1963) Pulmonary alveolar proteinosis: a new technique and rationale for treatment. Arch Intern Med 112: 419-431.
45. Reed, J.A., Ikegami, M., Cianciolo, E.R., Lu, W., Cho, P.S., Hull, W. et al. (1999) Aerosolized GM-CSF ameliorates pulmonary alveolar proteinosis in GM-CSF-deficient mice. Am J Physiol 276: L556-L563.
46. Riker, J.B. ( 1973) Trypsin aerosol treatment of pulmonary alveolar proteinosis. Am Rev Respir Dis 108: 108-113.
47. Rodi, G., Iotti, G., Galbusera, C., Mencherini, S., Raimondi, F. and Braschi, A. ( 1995) Whole lung lavage. Monaldi Arch Chest Dis 1: 64-66.
48. Rosen, S.G., Castelman, B. and Liebow, A.A. ( 1958) Pulmonary alveolar proteinosis. N Engl J Med 258: 1123-1142.
49. Sakagami, T., Uchida, K., Suzuki, T., Carey, B.C., Wood, R.E., Wert, S.E. et al. (2009) Human GM-CSF autoantibodies and reproduction of pulmonary alveolar proteinosis. N Engl J Med 361: 2679-2681.
50. Santamaria, F., Brancaccio, G., Parenti, G., Francalanci, P., Squitieri, C., Sebastio, G. et al. (2004) Recurrent fatal pulmonary alveolar proteinosis after heart-lung transplantation in a child with lysinuric protein intolerance. J Pediatr 145: 268-272.
51. Selecky, P.A., Wasserman, K., Bonfield, J.R. and Lippmann, M. ( 1977) The clinical and physiological effect of whole lung lavage in pulmonary alveolar proteinosis: a ten-year experience. Ann Thorac Surg 24: 451-461.
52. Seymour, J.F., Doyle, I.R., Nakata, K., Presneill, J.J., Schoch, O.D., Hamano, E. et al. (2003) Relationship of anti-GM-CSF antibody concentration, surfactant protein A and B levels, and serum LDH to pulmonary parameters and response to GM-CSF therapy in patients with idiopathic pulmonary alveolar proteinosis. Thorax 58: 252-257.
53. Seymour, J.F., Dunn, A.R., Vincent, J.M., Presneill, J.J. and Pain, M.C. ( 1996) Efficacy of granulocytemacrophage colony-stimulating factor in acquired alveolar proteinosis. N Engl J Med 335: 1924-1925.
54. Seymour, J.F. and Presneill, J.J. ( 2002) Pulmonary alveolar proteinosis: progress in the first 44 years. Am J Respir Crit Care Med 166: 215-235.
55. Seymour, J.F., Presneill, J.J., Schoch, O.D., Downie, G.H., Moore, P.E., Doyle, I.R. et al. (2001) Therapeutic effect of granulocyte-macrophage colony-stimulating factor in patients with idiopathic acquired alveolar proteinosis. Am J Respir Crit Care Med 163: 524-531.
56. Shah, P.L., Hansell, D., Lawson, Pr., Reid, K.B. and Morgan, C. ( 2000) Pulmonary alveolar proteinosis: clinical aspects and current concepts on pathogenesis. Thorax 55: 67-77.
57. Sihoe, A.D.L., Liu, R.W.T. and Lik-Cheung, C. ( 2008) Pulmonary alveolar proteinosis in extremis: the case for aggressive whole lung lavage with extracorporeal membrane oxygenation support. Heart, Lung Circulat 17: 62-79.
58. Sivitanidis, E., Tosson, R., Wiebalck, A. and Laczkovics, A. ( 1999) Combination of extracorporeal membrane oxygenation (ECMO) and pulmonary lavage in a patient with pulmonary alveolar proteinosis. Eur J Cardiothor Surg 15: 370-372.
59. Stanley, E., Lieschke, G.J., Grail, D., Metcalf, D., Hodgson, G., Gall, G.A. et al. (1994) Granulocytemacrophage colony-stimulating-factor deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology. Proc Natl Acad Sci U S A 91: 5592-5596.
60. Suzuki, T., Sakagami, T., Rubin, B.K., Nogee, L.M., Wood, R.E., Zimmermann, S.L. et al. (2008) Familial pulmonary alveolar proteinosis caused by mutations in SCF2RA. J Exp Med 205: 2703-2710.
61. Suzuki, T., Sakagami, T., Young, L., Carey, B.C., Wood, R.E., Luisetti, M. et al. (2010). Hereditary pulmonary alveolar proteinosis: pathogenesis, presentation, diagnosis, and therapy. In press.
62. Tanaka, N., Watanabe, J., Kitamura, T., Yamada, Y., Kanegasaki, S. and Nakata, K. ( 1999) Lungs of patients with idiopathic pulmonary alveolar proteinosis express a factor which neutralizes granulocyte-macrophage factor. FEBS Lett 442: 246-250.
63. Tazawa, R., Hamano, E., Arai, T., Ohta, H., Ishimoto, O., Uchida, K. et al. (2005) Granulocyte-macrophage colony-stimulating factor and lung immunity in pulmonary alveolar proteinosis. Am J Respir Crit Care Med 171: 1142-1149.
64. Tazawa, R., Trapnell, B.C., Inoue, Y., Arai, T., Takada, T., Nasuhara, Y., Hizawa, N. et al. (2010) Inhaled granulocyte-macrophage colony stimulating factor as therapy for pulmonary alveolar proteinosis. Am J Respir Crit Care Med 181: 1345-1354.
65. Trapnell, B.C., Whitsett, J.A. and Nakata, K. ( 2003) Pulmonary alveolar proteinosis. N Engl J Med 349: 2527-2539.
66. Venkateshish, S.B., Yan, T.D., Bonfield, T.L., Thomassen, M.J., Meziane, M., Czich, C. et al. (2006) An open-label trial of granulocyte-macrophage colony stimulating factor therapy for moderate symptomatic pulmonary alveolar proteinosis. Chest 130: 227-237.
67. Wasserman, K. and Mason, G.R. ( 1994) Pulmonary alveolar proteinosis, In: Murray, J.F. and Nadel, J.A. (eds). Textbook of Respiratory Medicine, 5th edition, Saunders: Philadelphia, PA, pp. 1933-1946.
68. Wylam, M.E., Ten, R., Prkash, U.B.S., Nadrous, H.F., Clawson, M.L. and Anderson, P.M. ( 2006) Aerosol granulocyte-macrophage colony stimulating factor for pulmonary alveolar proteinosis. Eur Respir J 27: 585-593.
69. Yamamoto, H., Yamaguchi, E., Agata, H., Kandatsu, N., Komatsu, T., Kawai, S. et al. (2008) A combination therapy of whole lung lavage and GM-CSF inhalation in pulmonary alveolar proteinosis. Ped Pulmonol 43: 828-830.
70. Zhou, B., Zhou, H., Xu, P., Wang, H., Lin, X. and Wang, X. ( 2009) Hyperoxygenated solution for improved oxygen supply in patients undergoing lung lavage for pulmonary alveolar proteinosis. Chin Med J 122: 1780-1783.